Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-16

Clinical Trial Update: Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial comparing levocetirizine with montelukast for reducing seasonal allergic rhinitis symptoms in ragweed-pollen–exposed subjects; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine (Levocetirizine)
  • Montelukast (Montelukast)

Snippet

Sponsor: UCB Pharma | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED